Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Summit Therapeutics plc (SMMT)

1.35 -0.05 (-3.57%)

11-16 16:00

Open:

1.37

Pre. Close:

1.4

High:

1.41

Low:

1.35

Volume:

13,301

Market Cap:

23M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.413 - 1.42

1.42 - 1.426

Low:

1.331 - 1.34

1.34 - 1.348

Close:

1.337 - 1.351

1.351 - 1.362

Technical analysis  (as of: 2018-11-16 4:37:40 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 2.12     One year: 2.45

Support:

Support1: 1.35    Support2: 1.12

Resistance:

Resistance1: 1.81    Resistance2: 2.10

Pivot:

1.56

Moving Averages:

MA(5): 1.40     MA(20): 1.64

MA(100): 2.13     MA(250): 8.36

MACD:

MACD(12,26): -0.16     Signal(12,26,9): -0.15

%K %D:

%K(14,3): 5.02     %D(3): 5.52

RSI:

RSI(14): 22.51

52-Week:

High: 15.9  Low: 1.35  Change(%): -88.5

Average Vol(K):

3-Month: 4942  10-Days 1964

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SMMT has closed above bottom band by 11.6%. Bollinger Bands are 79.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to SMMT's normal range. The bands have been in this narrow range for 86 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-10-03T12:33:30-04:00
Antibiotic developers in the green on Paratek news

2018-10-03T09:14:00-04:00
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2018

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Drug Manufacturers - Specialty Generic

Shares Out. (M)

16.43

Shares Float (M)

16.43

% Held by Insiders

% Held by Institutions

82.30

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

-0.100

EPS Est. Current Year

-0.530

EPS Est. Next Year

-1.050

EPS Est. Next Quarter

-0.620

Forward EPS

-1.971

Book Value (p.s.)

4.540

PEG Ratio

Profit Margin

20.73

Operating Margin

26.54

Return on Assets (ttm)

49.4

Return on Equity (ttm)

118.9

Qtrly Rev. Growth

744.5

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.240

Qtrly Earnings Growth

Operating Cash Flow (M)

-45.26

Levered Free Cash Flow (M)

6.13

Valuation

P/E

-13.50

P/E Growth Ratio

-0.04

P/BV

0.30

P/S

18236104.00

P/CF

-0.49

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.